FDA 483 - Mikart LLC - January 18, 2019

Mikart Inc, a drug manufacturer in Atlanta, GA, was cited for two significant issues during an FDA inspection. Observations included failures to properly quarantine incoming raw materials according to standard operating procedures and insufficient frequency of cGMP training for packaging operators and mechanics. These conditions indicate a lack of adherence to established procedures and regulatory requirements.